152 related articles for article (PubMed ID: 25050159)
1. Investigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonists.
He S; Lai Z; Ye Z; Dobbelaar PH; Shah SK; Truong Q; Du W; Guo L; Liu J; Jian T; Qi H; Bakshi RK; Hong Q; Dellureficio J; Reibarkh M; Samuel K; Reddy VB; Mitelman S; Tong SX; Chicchi GG; Tsao KL; Trusca D; Wu M; Shao Q; Trujillo ME; Fernandez G; Nelson D; Bunting P; Kerr J; Fitzgerald P; Morissette P; Volksdorf S; Eiermann GJ; Li C; Zhang B; Howard AD; Zhou YP; Nargund RP; Hagmann WK
ACS Med Chem Lett; 2014 Jul; 5(7):748-53. PubMed ID: 25050159
[TBL] [Abstract][Full Text] [Related]
2. SAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonists.
He S; Dobbelaar PH; Guo L; Ye Z; Liu J; Jian T; Truong Q; Shah SK; Du W; Qi H; Bakshi RK; Hong Q; Dellureficio JD; Sherer E; Pasternak A; Feng Z; Reibarkh M; Lin M; Samuel K; Reddy VB; Mitelman S; Tong SX; Chicchi GG; Tsao KL; Trusca D; Wu M; Shao Q; Trujillo ME; Fernandez G; Nelson D; Bunting P; Kerr J; Fitzgerald P; Morissette P; Volksdorf S; Eiermann GJ; Li C; Zhang BB; Howard AD; Zhou YP; Nargund RP; Hagmann WK
Bioorg Med Chem Lett; 2016 Mar; 26(6):1529-1535. PubMed ID: 26898814
[TBL] [Abstract][Full Text] [Related]
3. Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes.
Shah SK; He S; Guo L; Truong Q; Qi H; Du W; Lai Z; Liu J; Jian T; Hong Q; Dobbelaar P; Ye Z; Sherer E; Feng Z; Yu Y; Wong F; Samuel K; Madiera M; Karanam BV; Reddy VB; Mitelman S; Tong SX; Chicchi GG; Tsao KL; Trusca D; Feng Y; Wu M; Shao Q; Trujillo ME; Eiermann GJ; Li C; Pachanski M; Fernandez G; Nelson D; Bunting P; Morissette P; Volksdorf S; Kerr J; Zhang BB; Howard AD; Zhou YP; Pasternak A; Nargund RP; Hagmann WK
ACS Med Chem Lett; 2015 May; 6(5):513-7. PubMed ID: 26005524
[TBL] [Abstract][Full Text] [Related]
4. Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs.
Fabris F; Yue Y; Qu Y; Chahine M; Sobie E; Lee P; Wieczorek R; Jiang XC; Capecchi PL; Laghi-Pasini F; Lazzerini PE; Boutjdir M
J Physiol; 2016 Nov; 594(21):6175-6187. PubMed ID: 27296897
[TBL] [Abstract][Full Text] [Related]
5. The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model.
Morissette P; Nishida M; Trepakova E; Imredy J; Lagrutta A; Chaves A; Hoagland K; Hoe CM; Zrada MM; Travis JJ; Zingaro GJ; Gerenser P; Friedrichs G; Salata JJ
J Pharmacol Toxicol Methods; 2013; 68(1):137-49. PubMed ID: 23649000
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced QT prolongation: Concordance of preclinical anesthetized canine model in relation to published clinical observations for ten CiPA drugs.
Koshman YE; Wilsey AS; Bird BM; Endemann AL; Sadilek S; Treadway J; Martin RL; Polakowski JS; Gintant GA; Mittelstadt SW
J Pharmacol Toxicol Methods; 2020; 103():106871. PubMed ID: 32360993
[TBL] [Abstract][Full Text] [Related]
7. The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes.
He S; Ye Z; Truong Q; Shah S; Du W; Guo L; Dobbelaar PH; Lai Z; Liu J; Jian T; Qi H; Bakshi RK; Hong Q; Dellureficio J; Pasternak A; Feng Z; deJesus R; Yang L; Reibarkh M; Bradley SA; Holmes MA; Ball RG; Ruck RT; Huffman MA; Wong F; Samuel K; Reddy VB; Mitelman S; Tong SX; Chicchi GG; Tsao KL; Trusca D; Wu M; Shao Q; Trujillo ME; Eiermann GJ; Li C; Zhang BB; Howard AD; Zhou YP; Nargund RP; Hagmann WK
ACS Med Chem Lett; 2012 Jun; 3(6):484-9. PubMed ID: 24900499
[TBL] [Abstract][Full Text] [Related]
8. Can non-clinical repolarization assays predict the results of clinical thorough QT studies? Results from a research consortium.
Park E; Gintant GA; Bi D; Kozeli D; Pettit SD; Pierson JB; Skinner M; Willard J; Wisialowski T; Koerner J; Valentin JP
Br J Pharmacol; 2018 Feb; 175(4):606-617. PubMed ID: 29181850
[TBL] [Abstract][Full Text] [Related]
9. BeKm-1, a peptide inhibitor of human ether-a-go-go-related gene potassium currents, prolongs QTc intervals in isolated rabbit heart.
Qu Y; Fang M; Gao B; Chui RW; Vargas HM
J Pharmacol Exp Ther; 2011 Apr; 337(1):2-8. PubMed ID: 21205913
[TBL] [Abstract][Full Text] [Related]
10. Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro.
Fanoe S; Jensen GB; Sjøgren P; Korsgaard MP; Grunnet M
Br J Clin Pharmacol; 2009 Feb; 67(2):172-9. PubMed ID: 19159406
[TBL] [Abstract][Full Text] [Related]
11. An Analysis of the Relationship Between Preclinical and Clinical QT Interval-Related Data.
Pollard CE; Skinner M; Lazic SE; Prior HM; Conlon KM; Valentin JP; Dota C
Toxicol Sci; 2017 Sep; 159(1):94-101. PubMed ID: 28903488
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic modelling of drug-induced QTc interval prolongation in man: prediction from in vitro human ether-à-go-go-related gene binding and functional inhibition assays and conscious dog studies.
Dubois VF; Casarotto E; Danhof M; Della Pasqua O
Br J Pharmacol; 2016 Oct; 173(19):2819-32. PubMed ID: 27427789
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation.
Gintant G
Pharmacol Ther; 2011 Feb; 129(2):109-19. PubMed ID: 20807552
[TBL] [Abstract][Full Text] [Related]
14. Effects of probucol, a typical hERG expression inhibitor, on in vivo QT interval prolongation in conscious dogs.
Nogawa H; Kawai T; Yajima M; Miura M; Ogawa T; Murakami K
Eur J Pharmacol; 2013 Nov; 720(1-3):29-37. PubMed ID: 24211675
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel somatostatin receptor subtype 5 (SSTR5) antagonists: Pharmacological studies and design to improve pharmacokinetic profiles and human Ether-a-go-go-related gene (hERG) inhibition.
Yamasaki T; Hirose H; Yamashita T; Takakura N; Morimoto S; Nakahata T; Kina A; Nakano Y; Okano Tamura Y; Sugama J; Odani T; Shimizu Y; Iwasaki S; Watanabe M; Maekawa T; Kasai S
Bioorg Med Chem; 2017 Aug; 25(15):4153-4162. PubMed ID: 28622905
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys.
Watson KJ; Gorczyca WP; Umland J; Zhang Y; Chen X; Sun SZ; Fermini B; Holbrook M; Van Der Graaf PH
J Pharmacol Toxicol Methods; 2011; 63(3):304-13. PubMed ID: 21419854
[TBL] [Abstract][Full Text] [Related]
17. Application of a systems pharmacology model for translational prediction of hERG-mediated QTc prolongation.
Gotta V; Yu Z; Cools F; van Ammel K; Gallacher DJ; Visser SA; Sannajust F; Morissette P; Danhof M; van der Graaf PH
Pharmacol Res Perspect; 2016 Dec; 4(6):e00270. PubMed ID: 28097003
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.
Tran PN; Sheng J; Randolph AL; Baron CA; Thiebaud N; Ren M; Wu M; Johannesen L; Volpe DA; Patel D; Blinova K; Strauss DG; Wu WW
PLoS One; 2020; 15(11):e0241362. PubMed ID: 33157550
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a crucial modulating role of the sodium channel in the QTc prolongation related to antipsychotics.
Silvestre JS; O'Neill MF; Prous JR
J Psychopharmacol; 2014 Apr; 28(4):329-40. PubMed ID: 24327451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
